Sort
64,565 grants matching “drug discovery”
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$979,886David S Stephens · Emory University · UM1 · FY2020 · AI
Core B: University of Kentucky Alzheimer's Disease Core Center
$979,876Gregory A Jicha · University Of Kentucky · P30 · FY2021 · AG
Targeting a Novel Regulator of Brain Aging and Alzheimer's Disease
$979,652Bruce A Yankner · Harvard Medical School · R01 · FY2018 · AG
Development of a Broad-Spectrum Inhibitor against Seasonal and Highly-Pathogenic Influenza Viruses
$979,627Richard K. Plemper · Georgia State University · R01 · FY2021 · AI
Nuclear Factor-kappaB in Ovarian Cancer
$979,598Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Biophysics of Large Membrane Channels
$979,591Sergey Bezrukov · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2010 · HD
Therapy Against Recalcitrant C. albicans Infection
$979,417Thomas A Dahl · Arietis · R44 · FY2012 · AI
Convergence Accelerator Phase I (RAISE): A Multi-Scale Open Knowledge Network for Precision Medicine
$979,204Sergio E Baranzini · University Of California-San Francisco · · FY2019 · TIP
A Phase III Trial to Validate HP 129Xe MRI as a Functional Pulmonary Biomarker in Pediatric Lung Disease
$979,115Kiarash Emami · Polarean, Inc. · R44 · FY2019 · HL
Molecular Mechanisms of the Blood Brain Barrier Function and Regulation
$979,016Chenghua Gu · Harvard Medical School · R35 · FY2024 · NS
ALZHEIMER AMYLOIDOGENESIS WITH NEW METHODS
$979,007Brigham And Women'S Hospital · P01 · FY2001 · AG
Developmental Funds
$978,906Stanton L Gerson · Case Western Reserve University · P30 · FY2022 · CA
Predicting Cancer Cell Response to Endogenous and Exogenous Perturbations at the Single Cell Level
$978,890Andrea Califano · Columbia University Health Sciences · R35 · FY2025 · CA
Genomic Medicine Implementation: The Personalized Medicine Program
$978,729Julie A. Johnson · University Of Florida · U01 · FY2014 · HG
Targeting a Novel Regulator of Brain Aging and Alzheimer's Disease
$978,427Bruce A Yankner · Harvard Medical School · R01 · FY2017 · AG
Identification of Gene Polymorphisms Associated with Infectious Diseases
$978,326Cheryl Winkler · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Genetics of Renal Disease in African Americans
$978,326Cheryl Winkler · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Multi-site longitudinal Integrated Neurocognitive and Sleep-Behavior Profiler for the Endophenotypic Classification of Dementia Subtypes (INSPECDS)
$978,121Chris Berka · Advanced Brain Monitoring, Inc. · R44 · FY2023 · AG
Modulation of the Innate Immune Response by Fisetin Derivatives for the Treatment of AD
$977,956William C Raschke · Virogenics, Inc. · R44 · FY2018 · AI
CLINICAL TRIAL PROTOCOLS FOR ACUTE ISCHEMIC STROKE
$977,861Steven Jay Warach · National Institute Of Neurological Disorders And Stroke · ZIA · FY2011 · NS
NOVEL INSIGHTS INTO CEREBRAL ISCHEMIC PATHOPHYSIOLOGY IN HUMANS
$977,861Steven Jay Warach · National Institute Of Neurological Disorders And Stroke · ZIA · FY2011 · NS
SBIR Phase II: High-capacity membrane for fast and selective capture of mRNA
$977,854Graham Temples · Purilogics, Llc · R44 · FY2021 · GM
FabI Inhibitors as Potent, Gut Microbiome-Sparing Antibiotics
$977,797Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2025 · AI
FabI Inhibitors as Potent, Gut Microbiome-Sparing Antibiotics
$977,797Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2024 · AI
FabI Inhibitors as Potent, Gut Microbiome-Sparing Antibiotics
$977,797Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2023 · AI